These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 618992)

  • 1. Thrombin binding to thrombasthenic platelets.
    White GC; Workman EF; Lundblad RL
    J Lab Clin Med; 1978 Jan; 91(1):76-82. PubMed ID: 618992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet membrane defects in Glanzmann's thrombasthenia. Evidence for decreased amounts of two major glycoproteins.
    Phillips DR; Agin PP
    J Clin Invest; 1977 Sep; 60(3):535-45. PubMed ID: 70433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation.
    Grainick HR; Williams SB; Coller BS
    J Clin Invest; 1985 Jan; 75(1):19-25. PubMed ID: 2981249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggregation to thrombin and collagen of platelets from a Glanzmann thrombasthenic patient lacking glycoproteins IIb and IIIa.
    McGregor L; Hanss M; Sayegh A; Calvette JJ; Trzeciak MC; Ville D; Catimel B; Viala JJ; Dechavanne M; McGregor JL
    Thromb Haemost; 1989 Nov; 62(3):962-7. PubMed ID: 2595666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulated Glanzmann's thrombasthenia platelets produced microvesicles. Microvesiculation correlates better to exposure of procoagulant surface than to activation of GPIIb-IIIa.
    Holme PA; Solum NO; Brosstad F; Egberg N; Lindahl TL
    Thromb Haemost; 1995 Dec; 74(6):1533-40. PubMed ID: 8772233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced surface expression and binding of fibronectin by thrombin-stimulated thrombasthenic platelets.
    Ginsberg MH; Forsyth J; Lightsey A; Chediak J; Plow EF
    J Clin Invest; 1983 Mar; 71(3):619-24. PubMed ID: 6826726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of thrombin to functionally defective platelets: a hypothesis on the nature of the thrombin receptor.
    Ganguly P
    Br J Haematol; 1977 Sep; 37(1):47-51. PubMed ID: 588478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the binding of an alloimmune and two murine monoclonal antibodies to the platelet glycoprotein IIb-IIIa complex receptor.
    Coller BS; Peerschke EI; Seligsohn U; Scudder LE; Nurden AT; Rosa JP
    J Lab Clin Med; 1986 Apr; 107(4):384-92. PubMed ID: 2420911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of an anti-thrombospondin monoclonal antibody (P8) that inhibits human blood platelet functions. Normal binding of P8 to thrombin-activated Glanzmann thrombasthenic platelets.
    Boukerche H; McGregor JL
    Eur J Biochem; 1988 Jan; 171(1-2):383-92. PubMed ID: 3338471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the binding of thrombospondin to human platelets and its association with the platelet cytoskeleton.
    Dubernard V; Legrand C
    J Lab Clin Med; 1991 Nov; 118(5):446-57. PubMed ID: 1940585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with congenital factor V deficiency have decreased factor Xa binding sites on their platelets.
    Miletich JP; Majerus DW; Majerus PW
    J Clin Invest; 1978 Oct; 62(4):824-31. PubMed ID: 701480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Binding of factor VIII/Willebrand to Bernard-Soulier and thrombasthenic platelets (author's transl)].
    Ruan C; Tobelem G; Caen JP
    Nouv Rev Fr Hematol (1978); 1981; 23(2):89-93. PubMed ID: 6794004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Glanzmann's thrombasthenia: a rare example of an integrin deficit].
    Perutelli P; Mori PG
    Recenti Prog Med; 1992 Oct; 83(10):577-81. PubMed ID: 1462042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A variant of Glanzmann's thrombasthenia with abnormal glycoprotein IIb-IIIa complexes in the platelet membrane.
    Nurden AT; Rosa JP; Fournier D; Legrand C; Didry D; Parquet A; Pidard D
    J Clin Invest; 1987 Mar; 79(3):962-9. PubMed ID: 3818957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced thrombin binding and aggregation in Bernard-Soulier platelets.
    Jamieson GA; Okumura T
    J Clin Invest; 1978 Mar; 61(3):861-4. PubMed ID: 641158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The perturbation of thrombin binding to human platelets by anions.
    Shuman MA; Majerus PW
    J Clin Invest; 1975 Oct; 56(4):945-50. PubMed ID: 1159095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new variant of Glanzmann's thrombasthenia (Strasbourg I). Platelets with functionally defective glycoprotein IIb-IIIa complexes and a glycoprotein IIIa 214Arg----214Trp mutation.
    Lanza F; Stierlé A; Fournier D; Morales M; André G; Nurden AT; Cazenave JP
    J Clin Invest; 1992 Jun; 89(6):1995-2004. PubMed ID: 1602006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of membrane surface proteins in Glanzmann's thrombasthenia.
    Holahan JR; White GC
    Blood; 1981 Jan; 57(1):174-81. PubMed ID: 7448409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro binding of an IgE protein to human platelets.
    Cines DB; van der Keyl H; Levinson AI
    J Immunol; 1986 May; 136(9):3433-40. PubMed ID: 3007618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on platelets of patients with inherited platelet disorders suggest that collagen-induced fibrinogen binding to membrane receptors requires secreted ADP but not released alpha-granule proteins.
    Legrand C; Nurden AT
    Thromb Haemost; 1985 Oct; 54(3):603-6. PubMed ID: 3003952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.